| Term 
 
        | Mediators of inflammation |  | Definition 
 
        | lipids (prostaglandins) amines (hisatamines, 5-hydroxytrypramine) small peptides (bradykinins) large peptides (IL-1) |  | 
        |  | 
        
        | Term 
 
        | Local mediators, related lipids synthesized from the same precursors using interrelated pathways |  | Definition 
 
        | prostaglandins thromboxanes leukotrienes HEPETEs HETEs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 20 carbon atoms (eiconanoids) produced in minute quantities by all tissues act locally, rapidly metabolized to inactive do not circulate in significant quantities |  | 
        |  | 
        
        | Term 
 
        | what does HPETE stand for |  | Definition 
 
        | hydroperoxy elcosa tetra enoic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hydroxy eicosa tetra enoic acids |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Arachidonic acid (AA) released by phospholipase A2 and other acyl hydrolases in a process controlled by hormones and other stimuli |  | 
        |  | 
        
        | Term 
 
        | What are the two major pathways in forming eicosanoids from AA   |  | Definition 
 
        | cyclooxygenase lipoxygenae |  | 
        |  | 
        
        | Term 
 
        | What is made using the cyclooxygenase pathway? |  | Definition 
 
        | prostaglandins thromboxanes COX-1 & COX-2 |  | 
        |  | 
        
        | Term 
 
        | what is made using the lipoxygenase pathway |  | Definition 
 
        | HPETE-HETE leukotrienes lipoxins |  | 
        |  | 
        
        | Term 
 
        | Remember that arachidonic acid is very... |  | Definition 
 
        | lipophilic so easily passes through membrane lots of carbon  |  | 
        |  | 
        
        | Term 
 
        | A variety of membrane receptors that operate via G proteins which subsequently activate or inhibit adenylyl cyclase or stimulate phospholipase C |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | local signals that fine tune response of specific cell type thromboxane(TXA2)platelet aggregation & vasoconstriction released in allergic or inflammatory    |  | 
        |  | 
        
        | Term 
 
        | many NSAIDS work by inhibting synthesis of... |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDS inhibit..... but not...... |  | Definition 
 
        | cyclooxygenase but NOT lipoxygenase |  | 
        |  | 
        
        | Term 
 
        | COX-1 or COX-2 is constituitive? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | COX 1 or 2 is inducible and associated with inflammation? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Side effect of COX 1 inhibition is... |  | Definition 
 
        | inability for form stomach protecting prostaglandins (acid goes up, mucus down) |  | 
        |  | 
        
        | Term 
 
        | Which NSAID irreversibly inactivates cyclooxygenase? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Do NSAIDS (other than aspirin) and salicylates reversibly or irreversibly inhibit COX? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin acetylates which COX isoenzyme? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Deacetylated acetylsalicyclic acid is salicylate which is... |  | Definition 
 
        | an NSAID in its own right (reversible) |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates actions |  | Definition 
 
        | anti-inflammatory action analgesic action anti-pyretic action |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates anti-inflammatory actions |  | Definition 
 
        | decreased formation of prostaglandins which mediate inflammation does not induce remission in arthritic   |  | 
        |  | 
        
        | Term 
 
        | which salicylate has NO anti-inflammatory effect |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | aspirin and other salicylates analgesic action |  | Definition 
 
        | decrease PGE2 synthesis = decrease pain used for low to moderate intensity pain better than opioids in pain with inflammation Acetaminophin = effective analgesic   |  | 
        |  | 
        
        | Term 
 
        | ______ may sensitive nerve endings to bradykinin, histamine, and other chemical mediators released locally by inflammatory process (Pain) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | set point of anterior hypothalmic thermoregulatory center is increase |  | 
        |  | 
        
        | Term 
 
        | Fever may be caused by PGE2 synthesis stimulated by endogenous pyrogen such as cytokine released by white cells in.... |  | Definition 
 
        | infection, hypersensitivity, malignancy, or inflammation |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates antipyretic actions |  | Definition 
 
        | impede PGE2 synthesis peripheral vasodilation and sweating caused by aspirin help dissipate heat in febrile patints no effect on normal body temp   |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates respiratory action therapeutic dose |  | Definition 
 
        | increase alveolar ventilation    |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates respiratory action higher doses |  | Definition 
 
        | work on respiratory center in medulla causing hyperventilation and respiratory alkalosis usually compensated for by kidneys |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates respiratory action toxic levels |  | Definition 
 
        | central respiratory paralysis and resultant respiratory acidosis from CO2 accumulation |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates GI effects COX 1 |  | Definition 
 
        | PGI2 (prostacyclin) inhibits gastric secretion PGE2 ad PGF2alpha -stimulate mucus (protect)   |  | 
        |  | 
        
        | Term 
 
        | Aspirin decreases PGE2 and PGF2-alpha which results in... |  | Definition 
 
        | increased gastric acid and decreased protective mucus |  | 
        |  | 
        
        | Term 
 
        | Because aspirin increases acid and decreases mucus it can cause... |  | Definition 
 
        | dyspepsia ulceration hemorrhage |  | 
        |  | 
        
        | Term 
 
        | Regular thrombotic actions |  | Definition 
 
        | TXA2 (COX1) increase platelet aggregation PGI2 (COX2) decrease platement aggregation (endothelial) endothelial cells usually winning so keeping platelets pretty cool |  | 
        |  | 
        
        | Term 
 
        | Aspirin in low doses can irreversily inhibit what? |  | Definition 
 
        | thromboxane (TXA2) production in platelets w/e affecting PGI2 production in the endothelial cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | reduced platelet aggregation resultingin an antithrombotic effect with a prolonged bleeding time |  | 
        |  | 
        
        | Term 
 
        | Platelets do not have the ability to resynthesize cyclo-oxygenase to make more... |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates actions on the kidneys |  | Definition 
 
        | prevent synthesis of PGE2 and PGI2 which maintain renal blood flow especially w/ circulating vasoconstrictors decrease prostaglandins = may cause retention of sodium and water and cause edema and hyperkalemia |  | 
        |  | 
        
        | Term 
 
        | Interstitial nephritis may occur with all NSAIDS except.... |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | External applications of NSAIDS |  | Definition 
 
        | salicylic acid applications  methyl salicylate (oil of wintergreen) |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates CV applications |  | Definition 
 
        | inhibit platelet aggregation (COX1) decrease TIAs, unstable angina, coronary artery thrombosis, closure of PDA   |  | 
        |  | 
        
        | Term 
 
        | Aspirin may decrease the incidence of... |  | Definition 
 
        | colon cancer (inhibiting COX 2) |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates Admin and Distribution |  | Definition 
 
        | absorbed through intact skin passively absorbed from stomach-->small intestine rectal absorption unreliable cross BBB and placenta |  | 
        |  | 
        
        | Term 
 
        | When given in low doses (<300 mg/day) aspirin is used for? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Low dose anti-thrombic effect of aspirin uses |  | Definition 
 
        | reduce recurrent MI reduce mortality post MI analgesia prophylactic aspirin w/ clin. manifestations of coronary dis. |  | 
        |  | 
        
        | Term 
 
        | Moderate doses of aspirin (300-2400 mg/day) used for... |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | High dose aspirin (2400-4000 mg/day) used for |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin is hydrolyzed to salicylate and acetic acid by.. |  | Definition 
 
        | esterases in tissues and blood |  | 
        |  | 
        
        | Term 
 
        | Salicylate is converted by liver to.... |  | Definition 
 
        | water-soluble conjugates, cleared by the kidney |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aspirin-->salicylate-->water-soluble conjugate |  | 
        |  | 
        
        | Term 
 
        | Analgesic dose half life of aspirin and other salicylates |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-inflammatory dose half life of aspirin and other salicylates |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Alkalinization of the urine promotes excretion....why? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects GI |  | Definition 
 
        | epigastric distress NV microscopic GI bleeding |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Blood |  | Definition 
 
        | inhibition of platelet aggregation prolonged bleeding time   |  | 
        |  | 
        
        | Term 
 
        | How long should a patient be off of aspirin prior to surgery? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Respiration toxic doses cause... |  | Definition 
 
        | respiratory depression combo of uncompensated respiratory and metabolic acidosis |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Metabolic processes |  | Definition 
 
        | salicylates in toxic quantities may cause hyperthermia inhibit oxidase phosphorylation |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Hypersensitivity |  | Definition 
 
        | about 15% of patients taking aspirin allergy |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Reyes syndrome |  | Definition 
 
        | ASA w/ viral infections, a fulminating hep. w/ cerebral edema seen in children- give acetaminophen instead |  | 
        |  | 
        
        | Term 
 
        | Aspirin and other salicylates adverse effects Salicylism   |  | Definition 
 
        | NV hyperventilation headache mental confusion dizziness tinnitus |  | 
        |  |